Zobrazeno 1 - 10
of 11
pro vyhledávání: '"S. A. Potthoff"'
Autor:
S. A. Potthoff, O. Vonend
Publikováno v:
Current Hypertension Reports. 19
With its high prevalence and the eminent number of undetected or poorly controlled patients, the management of arterial hypertension is still a challenging task. Uncontrolled blood pressure is the major adjustable risk factor for cardiovascular end o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85d68cc816c1d4efff533dd4f33eba7d
https://doi.org/10.1007/s11906-017-0698-1
https://doi.org/10.1007/s11906-017-0698-1
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 137:2480-2484
Der Primare Hyperaldosteronismus (PHA) ist durch eine erhohte, vom Renin-Angiotensin-Aldosteron-System (RAAS) entkoppelte Aldosteronproduktion charakterisiert. Bei Patienten, die sich in spezialisierten Zentren zur Hypertoniebehandlung vorstellen, li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dac38042131e76a76dcba459f8ebce77
https://doi.org/10.1055/s-0032-1327318
https://doi.org/10.1055/s-0032-1327318
Autor:
S A, Potthoff, H G, Münch
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 138(24)
Iron deficiency often occurs in patients with chronic kidney disease and can be effectively treated with parenteral supplementation of iron. In these patients, prompt application of iron therapy can help to reduce the dependence of erythropoietin-sti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1718299172ae4ccd9ff4c3417730ff3e
https://pubmed.ncbi.nlm.nih.gov/23737117
https://pubmed.ncbi.nlm.nih.gov/23737117
Autor:
S. J. Potthoff
Publikováno v:
Molecular Endocrinology. 10:1095-1106
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::665be9fbd16ce0fd19af288fcf6846a2
https://doi.org/10.1210/me.10.9.1095
https://doi.org/10.1210/me.10.9.1095
Autor:
S A, Potthoff, D, Blondin
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 137(48)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7d8aefafa37790d7932166cae65e562b
https://pubmed.ncbi.nlm.nih.gov/23168981
https://pubmed.ncbi.nlm.nih.gov/23168981
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 137(48)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b8079654a8523d70932d5f2fa910925b
https://pubmed.ncbi.nlm.nih.gov/23168978
https://pubmed.ncbi.nlm.nih.gov/23168978
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 137(48)
Primary hyperaldosteronism (PHA) is characterized by an increased Aldosterone synthesis which is independent of the Renin-Angiotensin-Aldosterone-System (RAAS). The prevalence of PHA in patients who present in specialized hypertension centers is appr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a3bd6beb7b526b0a2a7ec3abeec97fbd
https://pubmed.ncbi.nlm.nih.gov/23168980
https://pubmed.ncbi.nlm.nih.gov/23168980
Autor:
F, Mahfoud, O, Vonend, H, Bruck, W, Clasen, S, Eckert, B, Frye, H, Haller, M, Hausberg, U C, Hoppe, J, Hoyer, K, Hahn, T, Keller, B K, Krämer, R, Kreutz, S A, Potthoff, H, Reinecke, R, Schmieder, V, Schwenger, U, Kintscher, M, Böhm, L C, Rump
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 136(47)
This commentary summarizes the expert consensus and recommendations of the working group 'Herz und Niere' of the German Society of Cardiology (DGK), the German Society of Nephrology (DGfN) and the German Hypertension League (DHL) on renal denervation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::01cc1aaa36a7e3db49a0ef1f1d907070
https://pubmed.ncbi.nlm.nih.gov/22048949
https://pubmed.ncbi.nlm.nih.gov/22048949
Autor:
J, Stegbauer, S A, Potthoff, I, Quack, E, Mergia, T, Clasen, S, Friedrich, O, Vonend, M, Woznowski, E, Königshausen, L, Sellin, L C, Rump
Publikováno v:
British journal of pharmacology. 163(5)
ApolipoproteinE-deficient [apoE (-/-)] mice, a model of human atherosclerosis, develop endothelial dysfunction caused by decreased levels of nitric oxide (NO). The endogenous peptide, angiotensin-(1-7) [Ang-(1-7)], acting through its specific GPCR, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::07f2118dc6252ac7c430d871e806c7c1
https://pubmed.ncbi.nlm.nih.gov/21371005
https://pubmed.ncbi.nlm.nih.gov/21371005
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 137:2475-2475
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a3fb5afa6f38a124ab2f64254ed0a01
https://doi.org/10.1055/s-0032-1327329
https://doi.org/10.1055/s-0032-1327329